Bridget E. Bunner

Array ( [id] => 1162283 [patent_doc_number] => 06759215 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Method of preparing human stem cell factor polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/635251 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 98 [patent_no_of_words] => 65013 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759215.pdf [firstpage_image] =>[orig_patent_app_number] => 09635251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601990 [patent_doc_number] => 06432406 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Method for reducing angiogenesis by administration of a scatter factor inhibitor' [patent_app_type] => B1 [patent_app_number] => 09/625820 [patent_app_country] => US [patent_app_date] => 2000-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 39 [patent_no_of_words] => 14617 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432406.pdf [firstpage_image] =>[orig_patent_app_number] => 09625820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1012589 [patent_doc_number] => 06897060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-24 [patent_title] => 'Composition comprising multipotent neural stem cells for generation of hematopoietic cells' [patent_app_type] => utility [patent_app_number] => 09/624199 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 9681 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897060.pdf [firstpage_image] =>[orig_patent_app_number] => 09624199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1059223 [patent_doc_number] => 06852313 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Method of stimulating growth of melanocyte cells by administering stem cell factor' [patent_app_type] => utility [patent_app_number] => 09/604325 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 95 [patent_no_of_words] => 51157 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852313.pdf [firstpage_image] =>[orig_patent_app_number] => 09604325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7976691 [patent_doc_number] => 08071092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-12-06 [patent_title] => 'Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha' [patent_app_type] => utility [patent_app_number] => 09/589288 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 162648 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071092.pdf [firstpage_image] =>[orig_patent_app_number] => 09589288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1027533 [patent_doc_number] => 06881401 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-19 [patent_title] => 'Methods of treatment of immune system related disorders using Neutrokine-alpha' [patent_app_type] => utility [patent_app_number] => 09/589285 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 162646 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/881/06881401.pdf [firstpage_image] =>[orig_patent_app_number] => 09589285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631450 [patent_doc_number] => 06635482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Monoclonal antibodies to membrane neutrokine-' [patent_app_type] => B1 [patent_app_number] => 09/589286 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 168138 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635482.pdf [firstpage_image] =>[orig_patent_app_number] => 09589286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1284273 [patent_doc_number] => 06638711 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation' [patent_app_type] => B1 [patent_app_number] => 09/560883 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 21839 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638711.pdf [firstpage_image] =>[orig_patent_app_number] => 09560883 [rel_patent_id] =>[rel_patent_doc_number] =>)